ALHC
insider transactionsAlignment Healthcare, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-399.1K
14.8K buy · 414.0K sell
Net value · 30d
-$8.2M
$197.6K in · $8.4M out
Sentiment · 30d
Net selling
2% buying · 98% selling
Open-market trades · 30d
7
14.8K buy · 414.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
EVP, Corporate Affairs · 10b5-1
$550.0K
25.0K sh · $22.00
Own -2%
-
Sell·S
President · 10b5-1
$586.4K
30.0K sh · $19.55
Own -3%
-
Sell·S
Chief Medical Officer · 10b5-1
$713.9K
36.0K sh · $19.86
Own -10%
-
Sell·S
EVP, Corporate Affairs · 10b5-1
$525.0K
25.0K sh · $21.00
Own -2%
-
Sell·S
John E Kao KEY
Chief Executive Officer · 10b5-1
$4.6M
223.1K sh · $20.60
Own -14%
-
Sell·S
John E Kao KEY
Chief Executive Officer · 10b5-1
$1.5M
74.9K sh · $19.65
Own -4%
-
Grant·A
Mark D. Kent KEY
President - MSO
$0
87.7K sh
Own +591%
-
Grant·A
EVP, Corporate Affairs
$0
122.8K sh
Own +11%
-
Buy·P
Mark D. Kent KEY
President - MSO
$197.6K
14.8K sh · $13.31
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Joseph S Konowiecki 10b5-1 | Sell S | 25.0K | $550.0K |
| Jun 15, 2026 | Dawn Christine Maroney KEY 10b5-1 | Sell S | 30.0K | $586.4K |
| Jun 12, 2026 | Hyong Kim 10b5-1 | Sell S | 36.0K | $713.9K |
| Jun 11, 2026 | Joseph S Konowiecki 10b5-1 | Sell S | 25.0K | $525.0K |
| Jun 10, 2026 | John E Kao KEY 10b5-1 | Sell S | 223.1K | $4.6M |
| Jun 10, 2026 | John E Kao KEY 10b5-1 | Sell S | 74.9K | $1.5M |
| Jun 3, 2026 | Mark D. Kent KEY | Grant A | 87.7K | $0 |
| Jun 3, 2026 | Joseph S Konowiecki | Grant A | 122.8K | $0 |
| Jun 2, 2026 | Mark D. Kent KEY | Buy P | 14.8K | $197.6K |
About ALHC insider trading
This page tracks insider transactions for Alignment Healthcare, Inc. (ALHC) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.